Cargando…
Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate
One of the possible causes of enhanced atherosclerosis in patients with chronic kidney disease (CKD) is the accumulation of uremic toxins. Since macrophage foam cell formation is a hallmark of atherosclerosis, we examined the direct effect of indoxyl sulfate (IS), a representative uremic toxin, on m...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549743/ https://www.ncbi.nlm.nih.gov/pubmed/26287243 http://dx.doi.org/10.3390/toxins7083155 |
_version_ | 1782387356955836416 |
---|---|
author | Matsuo, Koji Yamamoto, Suguru Wakamatsu, Takuya Takahashi, Yoshimitsu Kawamura, Kazuko Kaneko, Yoshikatsu Goto, Shin Kazama, Junichiro J. Narita, Ichiei |
author_facet | Matsuo, Koji Yamamoto, Suguru Wakamatsu, Takuya Takahashi, Yoshimitsu Kawamura, Kazuko Kaneko, Yoshikatsu Goto, Shin Kazama, Junichiro J. Narita, Ichiei |
author_sort | Matsuo, Koji |
collection | PubMed |
description | One of the possible causes of enhanced atherosclerosis in patients with chronic kidney disease (CKD) is the accumulation of uremic toxins. Since macrophage foam cell formation is a hallmark of atherosclerosis, we examined the direct effect of indoxyl sulfate (IS), a representative uremic toxin, on macrophage function. Macrophages differentiated from THP-1 cells were exposed to IS in vitro. IS decreased the cell viability of THP-1 derived macrophages but promoted the production of inflammatory cytokines (IL-1β, IS 1.0 mM: 101.8 ± 21.8 pg/mL vs. 0 mM: 7.0 ± 0.3 pg/mL, TNF-α, IS 1.0 mM: 96.6 ± 11.0 pg/mL vs. 0 mM: 15.1 ± 3.1 pg/mL) and reactive oxygen species. IS reduced macrophage cholesterol efflux (IS 0.5 mM: 30.3% ± 7.3% vs. 0 mM: 43.5% ± 1.6%) and decreased ATP-binding cassette transporter G1 expression. However, lipid uptake into cells was not enhanced. A liver X receptor (LXR) agonist, T0901317, improved IS-induced production of inflammatory cytokines as well as reduced cholesterol efflux. In conclusion, IS induced inflammatory reactions and reduced cholesterol efflux in macrophages. Both effects of IS were improved with activation of LXR. Direct interactions of uremic toxins with macrophages may be a major cause of atherosclerosis acceleration in patients with CKD. |
format | Online Article Text |
id | pubmed-4549743 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-45497432015-08-31 Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate Matsuo, Koji Yamamoto, Suguru Wakamatsu, Takuya Takahashi, Yoshimitsu Kawamura, Kazuko Kaneko, Yoshikatsu Goto, Shin Kazama, Junichiro J. Narita, Ichiei Toxins (Basel) Article One of the possible causes of enhanced atherosclerosis in patients with chronic kidney disease (CKD) is the accumulation of uremic toxins. Since macrophage foam cell formation is a hallmark of atherosclerosis, we examined the direct effect of indoxyl sulfate (IS), a representative uremic toxin, on macrophage function. Macrophages differentiated from THP-1 cells were exposed to IS in vitro. IS decreased the cell viability of THP-1 derived macrophages but promoted the production of inflammatory cytokines (IL-1β, IS 1.0 mM: 101.8 ± 21.8 pg/mL vs. 0 mM: 7.0 ± 0.3 pg/mL, TNF-α, IS 1.0 mM: 96.6 ± 11.0 pg/mL vs. 0 mM: 15.1 ± 3.1 pg/mL) and reactive oxygen species. IS reduced macrophage cholesterol efflux (IS 0.5 mM: 30.3% ± 7.3% vs. 0 mM: 43.5% ± 1.6%) and decreased ATP-binding cassette transporter G1 expression. However, lipid uptake into cells was not enhanced. A liver X receptor (LXR) agonist, T0901317, improved IS-induced production of inflammatory cytokines as well as reduced cholesterol efflux. In conclusion, IS induced inflammatory reactions and reduced cholesterol efflux in macrophages. Both effects of IS were improved with activation of LXR. Direct interactions of uremic toxins with macrophages may be a major cause of atherosclerosis acceleration in patients with CKD. MDPI 2015-08-14 /pmc/articles/PMC4549743/ /pubmed/26287243 http://dx.doi.org/10.3390/toxins7083155 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Matsuo, Koji Yamamoto, Suguru Wakamatsu, Takuya Takahashi, Yoshimitsu Kawamura, Kazuko Kaneko, Yoshikatsu Goto, Shin Kazama, Junichiro J. Narita, Ichiei Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate |
title | Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate |
title_full | Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate |
title_fullStr | Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate |
title_full_unstemmed | Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate |
title_short | Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate |
title_sort | increased proinflammatory cytokine production and decreased cholesterol efflux due to downregulation of abcg1 in macrophages exposed to indoxyl sulfate |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549743/ https://www.ncbi.nlm.nih.gov/pubmed/26287243 http://dx.doi.org/10.3390/toxins7083155 |
work_keys_str_mv | AT matsuokoji increasedproinflammatorycytokineproductionanddecreasedcholesteroleffluxduetodownregulationofabcg1inmacrophagesexposedtoindoxylsulfate AT yamamotosuguru increasedproinflammatorycytokineproductionanddecreasedcholesteroleffluxduetodownregulationofabcg1inmacrophagesexposedtoindoxylsulfate AT wakamatsutakuya increasedproinflammatorycytokineproductionanddecreasedcholesteroleffluxduetodownregulationofabcg1inmacrophagesexposedtoindoxylsulfate AT takahashiyoshimitsu increasedproinflammatorycytokineproductionanddecreasedcholesteroleffluxduetodownregulationofabcg1inmacrophagesexposedtoindoxylsulfate AT kawamurakazuko increasedproinflammatorycytokineproductionanddecreasedcholesteroleffluxduetodownregulationofabcg1inmacrophagesexposedtoindoxylsulfate AT kanekoyoshikatsu increasedproinflammatorycytokineproductionanddecreasedcholesteroleffluxduetodownregulationofabcg1inmacrophagesexposedtoindoxylsulfate AT gotoshin increasedproinflammatorycytokineproductionanddecreasedcholesteroleffluxduetodownregulationofabcg1inmacrophagesexposedtoindoxylsulfate AT kazamajunichiroj increasedproinflammatorycytokineproductionanddecreasedcholesteroleffluxduetodownregulationofabcg1inmacrophagesexposedtoindoxylsulfate AT naritaichiei increasedproinflammatorycytokineproductionanddecreasedcholesteroleffluxduetodownregulationofabcg1inmacrophagesexposedtoindoxylsulfate |